<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">60470</article-id><article-id pub-id-type="doi">10.7554/eLife.60470</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Differential impact of BTK active site inhibitors on the conformational state of full-length BTK</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-9229"><name><surname>Joseph</surname><given-names>Raji E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-197767"><name><surname>Amatya</surname><given-names>Neha</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9231"><name><surname>Fulton</surname><given-names>D Bruce</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-119561"><name><surname>Engen</surname><given-names>John R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6918-9476</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-197768"><name><surname>Wales</surname><given-names>Thomas E</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-182970"><name><surname>Andreotti</surname><given-names>Amy</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6952-7244</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Biochemistry, Biophysics &amp; Molecular Biology</institution>, <institution>Iowa State University</institution>, <addr-line><named-content content-type="city">Ames</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology</institution>, <institution>Iowa State University</institution>, <addr-line><named-content content-type="city">Ames</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Chemistry and Chemical Biology</institution>, <institution>Northeastern University</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1018"><name><surname>Kuriyan</surname><given-names>John</given-names></name><role>Reviewing editor</role><aff><institution>University of California, Berkeley</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>T.Wales@northeastern.edu</email> (TW);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>amyand@iastate.edu</email> (AA);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>11</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e60470</elocation-id><history><date date-type="received"><day>27</day><month>06</month><year>2020</year></date><date date-type="accepted"><day>20</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Joseph et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Joseph et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-60470-v1.pdf"/><abstract><p>Bruton's tyrosine kinase (BTK) is targeted in the treatment of B-cell disorders including leukemias and lymphomas. Currently approved BTK inhibitors, including Ibrutinib, a first-in-class covalent inhibitor of BTK, bind directly to the kinase active site. While effective at blocking the catalytic activity of BTK, consequences of drug binding on the global conformation of full-length BTK are unknown. Here we uncover a range of conformational effects in full-length BTK induced by a panel of active site inhibitors, including large-scale shifts in the conformational equilibria of the regulatory domains. Additionally, we find that a remote Ibrutinib resistance mutation, T316A in the BTK SH2 domain, drives spurious BTK activity by destabilizing the compact autoinhibitory conformation of full-length BTK, shifting the conformational ensemble away from the autoinhibited form. Future development of BTK inhibitors will need to consider long-range allosteric consequences of inhibitor binding, including the emerging application of these BTK inhibitors in treating COVID-19.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>AI43957</award-id><principal-award-recipient><name><surname>Andreotti</surname><given-names>Amy</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Hydrogen/deuterium exchange data have been deposited in the PRIDE database.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Wales TE</collab><collab>Engen JR</collab></person-group><year iso-8601-date="2020">2020</year><source>BTK regulatory domains escape Ibrutinib inhibition</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD020029">https://www.ebi.ac.uk/pride/archive/projects/PXD020029</ext-link><comment>PRIDE database, PXD020029</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-60470-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>